PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects

计划入组 12 人 · 首次发布于 2021 年 11 月 3 日

Evaluation the Topical Apremilast Nanoformulation in Treatment of Localized Plaque Psoriasis

计划入组 36 人 · 首次发布于 2026 年 1 月 26 日

PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.

计划入组 16 人 · 首次发布于 2025 年 4 月 8 日

Nanoformed piroxicam (Nanoform)

Piroxicam(Feldene)

C₁₅H₁₃N₃O₄S

NASOFORM LLC

United States

Nanoform Receives European Commercial cGMP License, Advances Multiple Nanoformulated Drug Programs

Nanoform Initiates Pivotal Bioequivalence Studies for Nanoenzalutamide Prostate Cancer Treatment

Nanoform Reports Strong Growth and Advances in Nanoparticle Drug Development Pipeline